DNA 6mA Demethylase ALKBH1 Orchestrates Fatty Acid Metabolism and Suppresses Diet-Induced Hepatic SteatosisSummary

Background & Aims: Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver-related morbidity and mortality whereas the pathogenic mechanism remains largely elusive. DNA N6-methyladenosine (6mA) modification is a recently identified epigenetic mark indicative of transcription in eu...

Full description

Bibliographic Details
Main Authors: Liping Luo, Ya Liu, Paul Nizigiyimana, Mingsheng Ye, Ye Xiao, Qi Guo, Tian Su, Xianghang Luo, Yan Huang, Haiyan Zhou
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Cellular and Molecular Gastroenterology and Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352345X22001928
_version_ 1817984165626249216
author Liping Luo
Ya Liu
Paul Nizigiyimana
Mingsheng Ye
Ye Xiao
Qi Guo
Tian Su
Xianghang Luo
Yan Huang
Haiyan Zhou
author_facet Liping Luo
Ya Liu
Paul Nizigiyimana
Mingsheng Ye
Ye Xiao
Qi Guo
Tian Su
Xianghang Luo
Yan Huang
Haiyan Zhou
author_sort Liping Luo
collection DOAJ
description Background & Aims: Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver-related morbidity and mortality whereas the pathogenic mechanism remains largely elusive. DNA N6-methyladenosine (6mA) modification is a recently identified epigenetic mark indicative of transcription in eukaryotic genomes. Here, we aimed to investigate the role and mechanism of DNA 6mA modification in NAFLD progression. Methods: Dot blot and immunohistochemistry were used to detect DNA 6mA levels. Liver-specific AlkB homolog 1 (ALKBH1)-knockout mice and mice with ALKBH1 overexpression in liver were subjected to a high-fat diet or methionine choline-deficient diet to evaluate the critical role of ALKBH1-demethylated DNA 6mA modification in the pathogenesis of hepatic steatosis during NAFLD. RNA sequencing and chromatin immunoprecipitation sequencing were performed to investigate molecular mechanisms underlying this process. Results: The DNA 6mA level was increased significantly with hepatic steatosis, while ALKBH1 expression was down-regulated markedly in both mouse and human fatty liver. Deletion of ALKBH1 in hepatocytes increased genomic 6mA levels and accelerated diet-induced hepatic steatosis and metabolic dysfunction. Comprehensive analyses of transcriptome and chromatin immunoprecipitation sequencing data indicated that ALKBH1 directly bound to and exclusively demethylated 6mA levels of genes involved in fatty acid uptake and lipogenesis, leading to reduced hepatic lipid accumulation. Importantly, ALKBH1 overexpression was sufficient to suppress lipid uptake and synthesis, and alleviated diet-induced hepatic steatosis and insulin resistance. Conclusions: Our findings show an indispensable role of ALKBH1 as an epigenetic suppressor of DNA 6mA in hepatic fatty acid metabolism and offer a potential therapeutic target for NAFLD treatment.
first_indexed 2024-04-13T23:42:05Z
format Article
id doaj.art-e5d92665d7564566b4bacf20d5ea9e45
institution Directory Open Access Journal
issn 2352-345X
language English
last_indexed 2024-04-13T23:42:05Z
publishDate 2022-01-01
publisher Elsevier
record_format Article
series Cellular and Molecular Gastroenterology and Hepatology
spelling doaj.art-e5d92665d7564566b4bacf20d5ea9e452022-12-22T02:24:29ZengElsevierCellular and Molecular Gastroenterology and Hepatology2352-345X2022-01-0114612131233DNA 6mA Demethylase ALKBH1 Orchestrates Fatty Acid Metabolism and Suppresses Diet-Induced Hepatic SteatosisSummaryLiping Luo0Ya Liu1Paul Nizigiyimana2Mingsheng Ye3Ye Xiao4Qi Guo5Tian Su6Xianghang Luo7Yan Huang8Haiyan Zhou9Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Endocrinology, Endocrinology Research Center, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Endocrinology, Endocrinology Research Center, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Endocrinology, Endocrinology Research Center, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Endocrinology, Endocrinology Research Center, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Endocrinology, Endocrinology Research Center, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Endocrinology, Endocrinology Research Center, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Endocrinology, Endocrinology Research Center, Xiangya Hospital, Central South University, Changsha, Hunan, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, Hunan, ChinaDepartment of Endocrinology, Endocrinology Research Center, Xiangya Hospital, Central South University, Changsha, Hunan, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, Hunan, ChinaDepartment of Endocrinology, Endocrinology Research Center, Xiangya Hospital, Central South University, Changsha, Hunan, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, Hunan, China; Correspondence Address correspondence to: Haiyan Zhou, PhD, Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital, Central South University, No 87, Xiangya Road, Changsha, Hunan Province 410008, China.Background & Aims: Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver-related morbidity and mortality whereas the pathogenic mechanism remains largely elusive. DNA N6-methyladenosine (6mA) modification is a recently identified epigenetic mark indicative of transcription in eukaryotic genomes. Here, we aimed to investigate the role and mechanism of DNA 6mA modification in NAFLD progression. Methods: Dot blot and immunohistochemistry were used to detect DNA 6mA levels. Liver-specific AlkB homolog 1 (ALKBH1)-knockout mice and mice with ALKBH1 overexpression in liver were subjected to a high-fat diet or methionine choline-deficient diet to evaluate the critical role of ALKBH1-demethylated DNA 6mA modification in the pathogenesis of hepatic steatosis during NAFLD. RNA sequencing and chromatin immunoprecipitation sequencing were performed to investigate molecular mechanisms underlying this process. Results: The DNA 6mA level was increased significantly with hepatic steatosis, while ALKBH1 expression was down-regulated markedly in both mouse and human fatty liver. Deletion of ALKBH1 in hepatocytes increased genomic 6mA levels and accelerated diet-induced hepatic steatosis and metabolic dysfunction. Comprehensive analyses of transcriptome and chromatin immunoprecipitation sequencing data indicated that ALKBH1 directly bound to and exclusively demethylated 6mA levels of genes involved in fatty acid uptake and lipogenesis, leading to reduced hepatic lipid accumulation. Importantly, ALKBH1 overexpression was sufficient to suppress lipid uptake and synthesis, and alleviated diet-induced hepatic steatosis and insulin resistance. Conclusions: Our findings show an indispensable role of ALKBH1 as an epigenetic suppressor of DNA 6mA in hepatic fatty acid metabolism and offer a potential therapeutic target for NAFLD treatment.http://www.sciencedirect.com/science/article/pii/S2352345X22001928DNA 6mAALKBH1DemethylationFatty LiverLipid Metabolism
spellingShingle Liping Luo
Ya Liu
Paul Nizigiyimana
Mingsheng Ye
Ye Xiao
Qi Guo
Tian Su
Xianghang Luo
Yan Huang
Haiyan Zhou
DNA 6mA Demethylase ALKBH1 Orchestrates Fatty Acid Metabolism and Suppresses Diet-Induced Hepatic SteatosisSummary
Cellular and Molecular Gastroenterology and Hepatology
DNA 6mA
ALKBH1
Demethylation
Fatty Liver
Lipid Metabolism
title DNA 6mA Demethylase ALKBH1 Orchestrates Fatty Acid Metabolism and Suppresses Diet-Induced Hepatic SteatosisSummary
title_full DNA 6mA Demethylase ALKBH1 Orchestrates Fatty Acid Metabolism and Suppresses Diet-Induced Hepatic SteatosisSummary
title_fullStr DNA 6mA Demethylase ALKBH1 Orchestrates Fatty Acid Metabolism and Suppresses Diet-Induced Hepatic SteatosisSummary
title_full_unstemmed DNA 6mA Demethylase ALKBH1 Orchestrates Fatty Acid Metabolism and Suppresses Diet-Induced Hepatic SteatosisSummary
title_short DNA 6mA Demethylase ALKBH1 Orchestrates Fatty Acid Metabolism and Suppresses Diet-Induced Hepatic SteatosisSummary
title_sort dna 6ma demethylase alkbh1 orchestrates fatty acid metabolism and suppresses diet induced hepatic steatosissummary
topic DNA 6mA
ALKBH1
Demethylation
Fatty Liver
Lipid Metabolism
url http://www.sciencedirect.com/science/article/pii/S2352345X22001928
work_keys_str_mv AT lipingluo dna6mademethylasealkbh1orchestratesfattyacidmetabolismandsuppressesdietinducedhepaticsteatosissummary
AT yaliu dna6mademethylasealkbh1orchestratesfattyacidmetabolismandsuppressesdietinducedhepaticsteatosissummary
AT paulnizigiyimana dna6mademethylasealkbh1orchestratesfattyacidmetabolismandsuppressesdietinducedhepaticsteatosissummary
AT mingshengye dna6mademethylasealkbh1orchestratesfattyacidmetabolismandsuppressesdietinducedhepaticsteatosissummary
AT yexiao dna6mademethylasealkbh1orchestratesfattyacidmetabolismandsuppressesdietinducedhepaticsteatosissummary
AT qiguo dna6mademethylasealkbh1orchestratesfattyacidmetabolismandsuppressesdietinducedhepaticsteatosissummary
AT tiansu dna6mademethylasealkbh1orchestratesfattyacidmetabolismandsuppressesdietinducedhepaticsteatosissummary
AT xianghangluo dna6mademethylasealkbh1orchestratesfattyacidmetabolismandsuppressesdietinducedhepaticsteatosissummary
AT yanhuang dna6mademethylasealkbh1orchestratesfattyacidmetabolismandsuppressesdietinducedhepaticsteatosissummary
AT haiyanzhou dna6mademethylasealkbh1orchestratesfattyacidmetabolismandsuppressesdietinducedhepaticsteatosissummary